BIT Biotech Opportunities S/ DE000A3DCA95 /
NAV20.06.2024 | Diff.+0,0500 | Ertragstyp | Ausrichtung | Fondsgesellschaft |
---|---|---|---|---|
129,2100EUR | +0,04% | thesaurierend | Aktien weltweit | HANSAINVEST ▶ |
GlobeNewswire
11:00
Defiance Launches QQQT, the NASDAQ 100 Income Target ETF. Seeks 20% annual yield